A COMBINATION OF A LONG-ACTING Beta2-AGONIST AND A GLUCOCORTICOSTEROID IN THE TREATMENT OF FIBROTIC DISEASES

• 1. 包含西替利嗪以及非β-2-肾上腺素受体激动剂、β-2-肾上腺素受体激动剂或消炎药的组合物及其用于治疗呼吸疾病的用途 [P] . 中国专利： CN101883562A . 2010-11-10
• 2. 作为用于治疗炎性疾病和糖尿病的糖皮质激素配体的1,1,1-三氟-4-苯基-4-甲基-2-(1H-吡咯并[2,3-C]吡啶-2-基甲基)戊-2-醇衍生物和相关化合物 [P] . 中国专利： CN1976705B . 2010.09.22
• 3. A COMBINATION OF A LONG-ACTING β2-AGONIST AND A GLUCOCORTICOSTEROID IN THE TREATMENT OF FIBROTIC DISEASES [P] . 世界知识产权组织专利： WO2004028545A1 . 2004-04-08

  机译： 长效β2-激动剂和糖皮质激素联合治疗纤维化疾病

• 4. A drug comprising a long-acting long-acting beta2-agonist in combination with other active ingredients [P] . 日本专利： JP2006519204A . 2006-08-24

  机译： 包含长效长效β2-激动剂和其他活性成分的药物

• 5. Combination of anticholinergics, glucocorticoids, beta2-agonists, PDE4 inhibitor and antileukotriene for the treatment of inflammatory diseases [P] . AU2012200449B2 . 2013-07-25

  机译： 抗胆碱能药，糖皮质激素，β2-激动剂，PDE4抑制剂和抗白三烯的组合治疗炎性疾病

• 1. The combination of disease and Zheng (syndrome) on the basic of differentiation of six channels:a new pattern of disease diagnosis and treatment of traditional Chinese medicine [J] . Xue Yang, Xiong-Zhi Wu 传统医学研究（英文版） . 2017,第002期
• 2. Real World Evidence of Safety and Effectiveness of Combination of Vitamin E and Fraxinus excelsiorin Treatment of Indian Patients with Nonalcoholic Fatty Liver Disease [J] . Virukalpatti Gopalratnam Mohan Prasad, Prashant Rahate, Husain Bohri, 肠胃病学期刊（英文） . 2020,第001期
• 3. Combination therapy of scalp electro-acupuncture and medication for the treatment of Parkinson's disease: A systematic review and meta-analysis [J] . Tianyao Qiang, Hongmei Sun, Cong Gai, 中医科学杂志（英文） . 2019,第001期
• 4. Rule-Based Combination of Comorbid Treatments for Chronic Diseases Applied to Hypertension, Diabetes Mellitus and Heart Failure [C] . Joan Albert Lopez-Vallverdu, David Riano, Antoni Collado International conference on business process management . 2013
• 5. Engineering an Integrated Microphysiological System for Modeling Human Fibrotic Disease [D] . Wendell, Max D. 2021
• 6. Long-acting beta2-agonist in addition to tiotropium versus either tiotropium or long-acting beta2-agonist alone for chronic obstructive pulmonary disease [O] . Charlotta Karner, Christopher J Cates -1
• 7. Differences in the efficacy and safety among inhaled corticosteroids (ICS)/long-acting beta2-agonists (LABA) combinations in the treatment of chronic obstructive pulmonary disease (COPD): Role of ICS [O] . Latorre M., Novelli F., Vagaggini B., 2015

• 1. Advances in treatment of neurodegenerative diseases: Perspectives for combination of stem cells with neurotrophic factors [J] . Jie Wang ,Wei-Wei Hu ,Zhi Jiang . 世界干细胞杂志：英文版（电子版） . 2020,第5期
• 2. The combination of disease and Zheng (syndrome) on the basic of differentiation of six channels:a new pattern of disease diagnosis and treatment of traditional Chinese medicine [J] . Xue Yang1 ,Xiong-Zhi Wu1 . 传统医学研究（TMR） . 2017,第002期
• 3. 长期吸入糖皮质激素/长效β2受体激动剂对慢性阻塞性肺疾病Ⅱ级稳定期患者D-二聚体的临床意义 [C] . 林晓英 ,严子兴 ,郑承铎 . 福州市科协2011年学术年会 . 2011
• 4. 吸入激素和长效β2受体激动剂联合治疗对哮喘控制的作用研究 [A] . 林科雄 . 2002